Algestone acetonide
| Clinical data | |
|---|---|
| Other names | W-3395; Alfasone acetonide; Alphasone acetonide; Algestone 16α,17α-acetonide; 16α,17α-Isopropylidenedioxyprogesterone; 16α,17α-(Isopropylidenedioxy)pregn-4-ene-3,20-dione | 
| Drug class | Progestin; Progestogen | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.023.280 | 
| Chemical and physical data | |
| Formula | C24H34O4 | 
| Molar mass | 386.532 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Algestone acetonide (developmental code name W-3395), also known as algestone 16α,17α-acetonide or 16α,17α-isopropylidenedioxyprogesterone, is a progestin which was never marketed. It is the acetonide cyclic ketal of algestone. Another progestin, algestone acetophenide, in contrast, has been marketed.